Several guidelines endorsed the indefinite use warfarin or heparin-containing products for acute venous thromboembolism (VTE) treatment and secondary prevention and discouraged the use of direct oral anticoagulants (DOAC) for patients diagnosed with antiphospholipid syndrome (APS). However. adequate anticoagulation despite warfarin therapy remains a challenge in APS patients. Using DO... https://www.bekindtopets.com/flash-find-Mega-CMPK-Bolus-50-ct-limited-choice/